会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Stable benzimidazole formulation
    • 稳定的苯并咪唑制剂
    • US07255878B1
    • 2007-08-14
    • US10018992
    • 2000-06-21
    • Erica Lahav, legal representativeValerie Azoulay
    • Raffael Lahav, deceased
    • A61K9/16A61K9/00A61K9/14A61K9/20A61K9/22
    • A61K9/2866A61K9/0053A61K9/2031A61K9/284A61K9/5078A61K31/4184A61K31/4439
    • A stable composition with a benzimidazole derivative, such as Omeprazole, which does not contain a separating layer between the active compound and an enteric coating layer. Instead, the enteric coating layer is applied as a solution with a pH value of at least 6.5, and more preferably in a range of from about 7 to about 10, directly to the benzimidazole derivative substrate. This solution, with the optional addition of a plasticizer, can be directly coated onto the substrate without any necessity for an intermediate layer. Furthermore, in this pH range, the enteric coating is optionally applicable in an aqueous solution, thereby obviating the need for organic solvents for dissolving the enteric coating material. The resultant formulation maintains the stability of the benzimidazole derivative during storage and at the same time protects the product during passage through the acidic environment of the stomach. The problem of interaction between the enteric coat and the alkaline core is thus completely eliminated as the enteric coat at this stage is no longer acidic.
    • 具有苯并咪唑衍生物如奥美拉唑的稳定组合物,其在活性化合物和肠溶衣层之间不含有分离层。 相反,将肠溶衣层作为pH值至少为6.5,更优选在约7至约10的范围内直接施用于苯并咪唑衍生物底物的溶液施用。 这种可选择地添加增塑剂的溶液可以直接涂覆在基材上,而不需要中间层。 此外,在该pH范围内,肠衣可以任选地应用于水溶液中,从而避免了溶解肠溶衣材料的有机溶剂的需要。 所得制剂在保存期间保持苯并咪唑衍生物的稳定性,同时在通过胃的酸性环境的过程中保护产物。 因此肠衣和碱性核心之间的相互作用的问题被完全消除,因为该阶段的肠衣不再是酸性的。
    • 4. 发明授权
    • Stable benzimidazole formulation
    • 稳定的苯并咪唑制剂
    • US09023391B2
    • 2015-05-05
    • US11785300
    • 2007-04-17
    • Valerie AzoulayErica Lahav
    • Raffael LahavValerie Azoulay
    • A61K9/00A61K9/14A61K31/4439A61K9/24A61P1/04B05D7/00A61K31/4184A61K9/20A61K9/28A61K9/50
    • A61K9/2866A61K9/0053A61K9/2031A61K9/284A61K9/5078A61K31/4184A61K31/4439
    • A stable composition with a benzimidazole derivative, such as Omeprazole, which does not contain a separating layer between the active compound and an enteric coating layer. Instead, the enteric coating layer is applied as a solution with a pH value of at least 6.5, and more preferably in a range of from about 7 to about 10, directly to the benzimidazole derivative substrate. This solution, with the optional addition of a plasticizer, can be directly coated onto the substrate without any necessity for an intermediate layer. Furthermore, in this pH range, the enteric coating is optionally applicable in an aqueous solution, thereby obviating the need for organic solvents for dissolving the enteric coating material. The resultant formulation maintains the stability of the benzimidazole derivative during storage and at the same time protects the product during passage through the acidic environment of the stomach. The problem of interaction between the enteric coat and the alkaline core is thus completely eliminated as the enteric coat at this stage is no longer acidic.
    • 具有苯并咪唑衍生物(例如奥美拉唑)的稳定组合物,其在活性化合物和肠溶衣层之间不含有分离层。 相反,将肠溶衣层作为pH值至少为6.5,更优选在约7至约10的范围内直接施用于苯并咪唑衍生物底物的溶液施用。 这种可选择地添加增塑剂的溶液可以直接涂覆在基材上,而不需要中间层。 此外,在该pH范围内,肠衣可以任选地应用于水溶液中,从而避免了溶解肠溶衣材料的有机溶剂的需要。 所得制剂在保存期间保持苯并咪唑衍生物的稳定性,同时在通过胃的酸性环境的过程中保护产物。 因此肠衣和碱性核心之间的相互作用的问题被完全消除,因为该阶段的肠衣不再是酸性的。
    • 5. 发明申请
    • STABLE BENZIMIDAZOLE FORMULATION
    • 稳定的苯并咪唑配方
    • US20120244219A1
    • 2012-09-27
    • US13456411
    • 2012-04-26
    • RAFFAEL LAHAVERICA LAHAVVALERIE AZOULAY
    • RAFFAEL LAHAVERICA LAHAVVALERIE AZOULAY
    • A61K9/00B05D7/00A61K9/14A61P1/04A61K31/4439A61K9/28
    • A61K9/2866A61K9/0053A61K9/2031A61K9/284A61K9/5078A61K31/4184A61K31/4439
    • A stable composition with a benzimidazole derivative, such as Omeprazole, which does not contain a separating layer between the active compound and an enteric coating layer. Instead, the enteric coating layer is applied as a solution with a pH value of at least 6.5, and more preferably in a range of from about 7 to about 10, directly to the benzimidazole derivative substrate. This solution, with the optional addition of a plasticizer, can be directly coated onto the substrate without any necessity for an intermediate layer. Furthermore, in this pH range, the enteric coating is optionally applicable in an aqueous solution, thereby obviating the need for organic solvents for dissolving the enteric coating material. The resultant formulation maintains the stability of the benzimidazole derivative during storage and at the same time protects the product during passage through the acidic environment of the stomach.
    • 具有苯并咪唑衍生物如奥美拉唑的稳定组合物,其在活性化合物和肠溶衣层之间不含有分离层。 相反,将肠溶衣层作为pH值至少为6.5,更优选在约7至约10的范围内直接施用于苯并咪唑衍生物底物的溶液施用。 这种可选择地添加增塑剂的溶液可以直接涂覆在基材上,而不需要中间层。 此外,在该pH范围内,肠衣可以任选地应用于水溶液中,从而避免了溶解肠溶衣材料的有机溶剂的需要。 所得制剂在保存期间保持苯并咪唑衍生物的稳定性,同时在通过胃的酸性环境的过程中保护产物。